Uricosuric effect of an anticholinergic agent in hyperuricemic subjects.
D003404:Creatinine / Q000378:metabolism; D003510:Cyclohexanes / Q000494:pharmacology; D006024:Glycopyrrolate / Q000494:pharmacology; D006073:Gout / Q000378:metabolism*; D006801:Humans; D010276:Parasympatholytics / Q000494:pharmacology*; D011412:Propanolamines / Q000494:pharmacology*; D011686:Purine-Pyrimidine Metabolism, Inborn Errors / Q000378:metabolism*; D011718:Pyrazinamide / Q000494:pharmacology; D011759:Pyrrolidines / Q000494:pharmacology*; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology*; D013997:Time Factors; D014527:Uric Acid / Q000378:metabolism*
D003510:Cyclohexanes; D010276:Parasympatholytics; D011412:Propanolamines; D011759:Pyrrolidines; D000644:Quaternary Ammonium Compounds; D014527:Uric Acid; D011718:Pyrazinamide; D003404:Creatinine; D006024:Glycopyrrolate